Method

Immunophenotyping assays (clinical)

Flow cytometry and related assays that identify and enumerate specific immune cell populations by surface marker expression, used to characterize immune status in clinical samples.

AI-generated definition

Scholars using this

View all 11 scholars →

JB
Juliet BarkerProfessor of Medicine
JB
Juliet BarkerProfessor of Medicine
RN
Rob N. PeckAssociate Professor of Medicine
RN
Rob N. PeckAssociate Professor of Medicine
EP
Edwin PatinoInstructor in Medicine
EP
Edwin PatinoInstructor in Medicine
CS
Cora SternbergProfessor of Medicine
CS
Cora SternbergProfessor of Medicine
MR
Michael Reid LorAssistant Professor of Clinical Dermatology
MR
Michael Reid LorAssistant Professor of Clinical Dermatology
AS
Ashish SaxenaAssociate Professor of Clinical Medicine
AS
Ashish SaxenaAssociate Professor of Clinical Medicine

Spotlight

Immunophenotyping assays (clinical)

CAChristine Ann Garcia XKXi Kathy Zhou ASAshish Saxena

Cancer treatment and research communications · 2026

Immunophenotyping assays (clinical)

SASebastian A. Mayer TBTsiporah B Shore AGAlexandra Gomez Arteaga JBJuliet Barker

Transplantation and cellular therapy · 2025

Immunophenotyping assays (clinical)

UWUlrike W. Kaunzner SASusan A. Gauthier JSJai S. Perumal

Ethnicity & disease · 2025

View all 12 publications →

Publications

Sort by

Immunophenotyping assays (clinical)

Scholars using this

Comprehensive clinical characteristics and outcomes of stage IV EGFR-mutant NSCLC based on PD-L1 expression.

Availability of Suitable Domestic Cord Blood Grafts for Adult Allograft Recipients With Hematologic Malignancies.

B-Cell-Targeted Therapies for Black vs White Americans with Relapsing Multiple Sclerosis.